20
Participants
Start Date
June 23, 2021
Primary Completion Date
July 31, 2024
Study Completion Date
June 30, 2026
IA session
10 IA sessions performed in 28 days maximum, using TherasorbTM adsorbers which contain sheep derived polyvalent antihuman-immunoglobulin coupled to SepharoseTM CL-4B.
Rituximab
"Concomitantly, Rituximab will be given each week for 4 weeks (one injection by week +/- 3 days):~* at least 1 day before each IA session~* the last injection will occur after the last session IA (minimum one day after)"
RECRUITING
Hôpital Necker Enfants-Malades, Paris
Assistance Publique - Hôpitaux de Paris
OTHER